TransMedics to Present at Upcoming March Investor Conferences
21 févr. 2023 16h05 HE
|
TransMedics
ANDOVER, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting
28 sept. 2020 16h05 HE
|
TransMedics
ANDOVER, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TransMedics to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
01 sept. 2020 16h30 HE
|
TransMedics
ANDOVER, Mass., Sept. 01, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TransMedics Reports Second Quarter 2020 Financial Results
05 août 2020 16h01 HE
|
TransMedics
ANDOVER, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics to Present at the Canaccord 40th Annual Growth Conference
28 juil. 2020 16h01 HE
|
TransMedics
ANDOVER, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics to Report Second Quarter 2020 Financial Results on August 5, 2020
23 juil. 2020 08h00 HE
|
TransMedics
ANDOVER, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Announces Pricing of Public Offering of Common Stock
26 mai 2020 18h49 HE
|
TransMedics
ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Announces Proposed Public Offering of Common Stock
26 mai 2020 07h14 HE
|
TransMedics
ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial
26 mai 2020 07h09 HE
|
TransMedics
ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Reports First Quarter 2020 Financial Results
06 mai 2020 16h05 HE
|
TransMedics
ANDOVER, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...